Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
about
Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysisNegative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis.Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis ReferraClinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn.Vasculitis for the internist: focus on ANCA-associated vasculitis.[Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)].The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis.Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Towards precision medicine in ANCA-associated vasculitis."Exercise induced asthma" is not always asthma.
P2860
Q28069646-6D0772FC-A3C7-416B-8CF8-D6DAF2982A7EQ33771970-CC0A0CC1-E846-48D8-A618-DA1C3330630AQ38647220-4863AD15-A04C-4982-A928-B6701B213724Q38873411-9A8D80B4-030A-4F4F-BE93-514A31CFAD2AQ39088103-B21CEEBF-912A-4F1F-804A-C4E928CD32CDQ39379384-1739C1B9-EA81-4C22-BBFD-1E0DC999B488Q40211205-D9655F99-80D8-48A1-B5E6-10889CA36748Q41592598-CA4CBED6-D3D6-46BB-AC3F-60EE863F81AEQ41687182-3366E532-28E3-480A-9C64-06BC3F25194EQ47552107-1F854919-CF9D-4CBA-9AA3-F41A2FD9B63BQ50014741-02650AA5-CE1A-4F9D-AE27-E19DC8CE281BQ50049397-D622285D-30E5-4367-9B29-D4C6F4BA83D0Q50076914-728BFD29-55B0-48B7-90C5-200F3651C22FQ50089937-894E31FF-A8D8-4DF5-A2A9-6F2AFC1CF7F1Q55491883-657E98F6-0017-44AC-8410-C79C59A98CBF
P2860
Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Long-Term Outcomes Among Parti ...... ) or Microscopic Polyangiitis.
@en
type
label
Long-Term Outcomes Among Parti ...... ) or Microscopic Polyangiitis.
@en
prefLabel
Long-Term Outcomes Among Parti ...... ) or Microscopic Polyangiitis.
@en
P2093
P2860
P50
P356
P1476
Long-Term Outcomes Among Parti ...... ) or Microscopic Polyangiitis.
@en
P2093
Amar Smail
Benjamin Terrier
Bernard Imbert
Catherine Hanrotel-Saliou
Chahéra Khouatra
Charles Leské
Christian Pagnoux
Claire Le Jeunne
Dominique Merrien
Edouard Pertuiset
P2860
P304
P356
10.1002/ART.39450
P577
2015-10-16T00:00:00Z